Joseph L Goldstein insider trades
Open-market stock purchases and sales by Joseph L Goldstein, Director at Regeneron Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 4, 2010.
Companies traded
- REGN Regeneron Pharmaceuticals, Inc: 103 sales, last Jan 2, 2026